Recovery With Virtual Reality for Stress and Pain (ReVRS)
Recovery With Virtual Reality for Stress & Pain (ReVRS)
Aperçu de l'étude
Statut
Statut
Les conditions
Les conditions
Intervention / Traitement
Intervention / Traitement
Description détaillée
Preoperative anxiety and postoperative pain may negatively affect patients' recovery after surgery. Virtual reality may provide a non-pharmacological method of distraction and relaxation, but its effect on perioperative anxiety and early postoperative recovery requires further evaluation.
This prospective, randomized, parallel-group controlled trial will include approximately 140 adults undergoing elective gynecological surgery. After providing informed consent, participants will be randomized in a 1:1 ratio to one of two groups:
- Virtual reality plus usual perioperative care.
- Usual perioperative care alone.
Participants assigned to the intervention group will use a virtual reality headset for approximately 10-20 minutes before surgery and view an immersive relaxation environment. The intervention may be discontinued at any time if the participant experiences discomfort, nausea, dizziness, anxiety, or other adverse symptoms.
The primary outcome is the change in preoperative anxiety from immediately before to immediately after the intervention period, assessed using the State-Trait Anxiety Inventory-State scale and/or a numerical rating scale for anxiety.
Secondary outcomes include quality of recovery measured with the Quality of Recovery-15 questionnaire, postoperative pain measured using a numerical rating scale, opioid consumption expressed as morphine milligram equivalents, postoperative nausea and vomiting, time spent in the postoperative care unit, and other indicators of early postoperative recovery. Follow-up assessments are planned at approximately 24 and 72 hours and on postoperative days 7 and 10.
The study will examine whether preoperative virtual reality reduces anxiety and whether any reduction is associated with improved postoperative recovery and reduced symptom burden.
Type d'étude
Type d'étude
Inscription (Estimé)
Inscription
Phase
Phase
- N'est pas applicable
Contacts et emplacements
Coordonnées de l'étude
Coordonnées de l'étude
- Nom: Pether Jildenstål, Professor
- Numéro de téléphone: +46 76-026 66 58
- E-mail: pether.jildenstal@med.lu.se
Critères de participation
Critère d'éligibilité
Critère d'éligibilité
Âges éligibles pour étudier
- Adulte
- Adulte plus âgé
Accepte les volontaires sains
La description
Inclusion Criteria:
- Adults aged 18 years or older.
- Scheduled to undergo elective gynecological surgery according to the study protocol at a participating center where virtual reality can be provided.
- Able and willing to provide informed consent for study participation, 1:1 randomization, and use of virtual reality.
Exclusion Criteria:
- Increased risk of adverse effects related to virtual reality, including pronounced motion sickness, claustrophobia, or photosensitive epilepsy.
- Active substance use disorder or active misuse of alcohol or illicit drugs.
- Severe chronic pain and/or regular preoperative opioid treatment, as defined in the study protocol.
Plan d'étude
Comment l'étude est-elle conçue ?
Détails de conception
- Objectif principal: Traitement
- Répartition: Randomisé
- Modèle interventionnel: Affectation parallèle
- Masquage: Aucun (étiquette ouverte)
Nombre de bras
Armes et Interventions
Groupe de participants / BrasGroupe de participants / Bras |
Intervention / TraitementIntervention / Traitement |
|---|---|
|
Expérimental: Virtual Reality Plus Usual Care
Participants receive a preoperative virtual reality session in addition to usual perioperative care.
The session lasts approximately 10-20 minutes and is delivered in the waiting or preoperative area using calm nature or relaxation scenes intended to promote comfort and distraction.
|
A single preoperative virtual reality session lasting approximately 10-20 minutes, administered in the waiting or preoperative area.
Participants view calm nature, relaxation, or guided-breathing scenes using a virtual reality headset.
The intervention is intended to provide relaxation, comfort, and distraction before surgery.
|
|
Comparateur actif: Usual Care
Participants receive usual perioperative care without virtual reality during the corresponding preoperative period.
|
Participants receive standard perioperative care according to local clinical routines.
No preoperative virtual reality session is provided during the corresponding intervention period.
|
Que mesure l'étude ?
Principaux critères de jugement
Principaux critères de jugement
Mesure des résultats |
Description de la mesure |
Délai |
|---|---|---|
|
Quality of Postoperative Recovery Measured With QoR-15
Délai: 24 hours after surgery
|
Postoperative recovery will be assessed using the 15-item Quality of Recovery questionnaire (QoR-15).
The total score ranges from 0 to 150, with higher scores indicating better quality of recovery.
|
24 hours after surgery
|
Mesures de résultats secondaires
Mesures de résultats secondaires
Mesure des résultats |
Description de la mesure |
Délai |
|---|---|---|
|
Change in Preoperative Anxiety
Délai: From immediately before to immediately after the intervention, approximately 10-20 minutes
|
Anxiety will be assessed before and after the preoperative intervention period using the anxiety measure specified in the study protocol.
Higher scores indicate greater anxiety.
|
From immediately before to immediately after the intervention, approximately 10-20 minutes
|
|
Postoperative Pain Intensity
Délai: Up to 72 hours after surgery
|
Postoperative pain will be assessed using a numerical rating scale from 0 to 10, where 0 indicates no pain and 10 indicates the worst imaginable pain.
|
Up to 72 hours after surgery
|
|
Postoperative Opioid Consumption
Délai: During the first 24 hours after surgery
|
Total postoperative opioid consumption will be calculated and converted to intravenous morphine milligram equivalents.
|
During the first 24 hours after surgery
|
|
Incidence of Postoperative Nausea and Vomiting
Délai: During the first 24 hours after surgery
|
Number and proportion of participants experiencing nausea, vomiting, or both during the postoperative period.
|
During the first 24 hours after surgery
|
|
Duration of Stay in the Post-Anesthesia Care Unit
Délai: On the day of surgery
|
Time from admission to discharge from the post-anesthesia care unit.
|
On the day of surgery
|
|
Quality of Recovery at 72 Hours Measured With QoR-15
Délai: 72 hours after surgery
|
Quality of postoperative recovery will be assessed using the 15-item Quality of Recovery questionnaire (QoR-15).
The total score ranges from 0 to 150, with higher scores indicating better quality of recovery.
|
72 hours after surgery
|
|
Quality of Recovery on Postoperative Day 7 Measured With QoR-15
Délai: 7 days after surgery
|
Quality of postoperative recovery will be assessed using the 15-item Quality of Recovery questionnaire (QoR-15).
The total score ranges from 0 to 150, with higher scores indicating better quality of recovery.
|
7 days after surgery
|
|
Quality of Recovery on Postoperative Day 10 Measured With QoR-15
Délai: 10 days after surgery
|
Quality of postoperative recovery will be assessed using the 15-item Quality of Recovery questionnaire (QoR-15).
The total score ranges from 0 to 150, with higher scores indicating better quality of recovery.
|
10 days after surgery
|
Collaborateurs et enquêteurs
Parrainer
Parrainer
Dates d'enregistrement des études
Dates principales de l'étude
Début de l'étude (Estimé)
Début de l'étude
Achèvement primaire (Estimé)
Achèvement primaire
Achèvement de l'étude (Estimé)
Achèvement de l'étude
Dates d'inscription aux études
Première soumission
Première soumission
Première soumission répondant aux critères de contrôle qualité
Première soumission répondant aux critères de contrôle qualité
Première publication (Réel)
Première publication
Mises à jour des dossiers d'étude
Dernière mise à jour publiée (Réel)
Dernière mise à jour publiée
Dernière mise à jour soumise répondant aux critères de contrôle qualité
Dernière mise à jour soumise répondant aux critères de contrôle qualité
Dernière vérification
Dernière vérification
Plus d'information
Termes liés à cette étude
Mots clés
Termes MeSH pertinents supplémentaires
Autres numéros d'identification d'étude
Autres numéros d'identification d'étude
- 2026-03077-01 (Autre identifiant: Swedish Ethical Review Authority)
Plan pour les données individuelles des participants (IPD)
Prévoyez-vous de partager les données individuelles des participants (DPI) ?
Description du régime IPD
Informations sur les médicaments et les dispositifs, documents d'étude
Étudie un produit pharmaceutique réglementé par la FDA américaine
Étudie un produit d'appareil réglementé par la FDA américaine
Ces informations ont été extraites directement du site Web clinicaltrials.gov sans aucune modification. Si vous avez des demandes de modification, de suppression ou de mise à jour des détails de votre étude, veuillez contacter register@clinicaltrials.gov. Dès qu'un changement est mis en œuvre sur clinicaltrials.gov, il sera également mis à jour automatiquement sur notre site Web .